How does established rheumatoid arthritis develop, and are there possibilities for prevention?

• Published in: Best practice & research. Clinical rheumatology Vol. 29; no. 4; pp. 527 - 542
• Main Authors: van Beers-Tas, Marian H, Turk, Samina A, van Schaardenburg, Dirkjan
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01-08-2015
• Subjects: Arthritis, Rheumatoid - diagnosis; Arthritis, Rheumatoid - etiology; Arthritis, Rheumatoid - prevention & control; Early and established rheumatoid arthritis; Early Diagnosis; Humans; Incidence; Preclinical; Prediction; Prevention; Rheumatology; Risk Factors; Undifferentiated arthritis; Prevention; Undifferentiated arthritis; Preclinical; Early and established rheumatoid arthritis; Risk factors; Prediction
• ISSN: 1521-6942; 1532-1770
• DOI: 10.1016/j.berh.2015.09.001

Abstract Established rheumatoid arthritis (RA) is a chronic state with more or less joint damage and inflammation, which persists after a phase of early arthritis. Autoimmunity is the main determinant of persistence. Although the autoimmune response is already fully developed in the phase of early arthritis, targeted treatment within the first months produces better results than delayed treatment. Prevention of established RA currently depends on the success of remission-targeted treatment of early disease. Early recognition is aided by the new criteria for RA. Further improvement may be possible by even earlier recognition and treatment in the at-risk phase. This requires the improvement of prediction models and strategies, and more intervention studies. Such interventions should also be directed at modifiable risk factors such as smoking and obesity. The incidence of RA has declined for decades in parallel with the decrease of smoking rates; however, a recent increase has occurred that is associated with obesity.